SCHEMBL24522320

SCHEMBL24522320

O=Cc1c(Cl)[nH]c2ccc(F)cc12

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.44
ALDH1A1 P00352 3/20 0.44
GLA P06280 1/20 0.44
GAA P10253 1/20 0.44
HTT P42858 1/20 0.44
KEAP1 Q14145 1/20 0.44
NFE2L2 Q16236 1/20 0.44
MAPT P10636 1/20 0.42
MAPK1 P28482 1/20 0.42
FEN1 P39748 1/20 0.41
PLK4 O00444 2/20 0.41
PLK1 P53350 2/20 0.41
PLK2 Q9NYY3 1/20 0.41
PLK3 Q9H4B4 1/20 0.41
ACHE P22303 2/20 0.41
KIF11 P52732 1/20 0.40
LMNA P02545 2/20 0.40
HPGD P15428 1/20 0.40
MPO P05164 1/20 0.40
METAP2 P50579 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27815827 0.83 PLK4 (0.50) KDM4EALDH1A1GLAGAAHTT
SCHEMBL22898794 0.82 LMNA (0.51) KDM4EALDH1A1GLAGAAMAPT
SCHEMBL29363428 0.82 LMNA (0.51) KDM4EALDH1A1GLAGAAMAPT
SCHEMBL29363427 0.79 KDM4E (0.46) KDM4EALDH1A1GAAMAPTMAPK1
SCHEMBL16920112 0.79 PIM1 (0.46) ALDH1A1MAPTMAPK1LMNAHPGD
SCHEMBL2062443 0.79 KEAP1 (0.51) KDM4EALDH1A1GLAGAAHTT
SCHEMBL29950892 0.79 CCNB2 (0.53) GAAACHEMEN1KMT2A
SCHEMBL24522294 0.79 KDM4E (0.46) KDM4EALDH1A1GAAMAPTMAPK1
SCHEMBL29951828 0.79 PIM1 (0.46) ALDH1A1MAPTMAPK1LMNAHPGD
SCHEMBL20625430 0.79 DAO (0.48) KDM4EALDH1A1GLAGAAHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114206857-B Benzofuranyl N-acylhydrazone derivatives and pharmaceutical compositions comprising the same 韩国生命工学研究院 2024-09-06 CN disclosed
US-20230293487-A1 ANTI-INFLAMMATORY COMPOSITION COMPRISING BENZOFURAN-BASED N-ACYLHYDRAZONE DERIVATIVES KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY (KR) 2023-09-21 US disclosed
US-20230293487-A1 ANTI-INFLAMMATORY COMPOSITION COMPRISING BENZOFURAN-BASED N-ACYLHYDRAZONE DERIVATIVES KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY (KR) 2023-09-21 US disclosed
EP-4186503-A1 ANTI-INFLAMMATORY COMPOSITION COMPRISING BENZOFURAN-BASED N-ACYLHYDRAZONE DERIVATIVES Korea Research Institute of Bioscience and Biotechnology (KR) 2023-05-31 EP disclosed
CN-116157120-A Anti-inflammatory compositions comprising benzofuranyl N-acylhydrazone derivatives 韩国生命工学研究院 2023-05-23 CN disclosed
EP-4015516-A1 BENZOFURAN-BASED N-ACYLHYDRAZONE DERIVATIVE AND PHARMACEUTICAL COMPOSITION COMPRISING SAME Korea Research Institute of Bioscience and Biotechnology (KR) 2022-06-22 EP disclosed
CN-114206857-A Benzofuranyl N-acylhydrazone derivatives and pharmaceutical compositions containing the same 韩国生命工学研究院 2022-03-18 CN disclosed
WO-2022019663-A1 ANTI-INFLAMMATORY COMPOSITION COMPRISING BENZOFURAN-BASED N-ACYLHYDRAZONE DERIVATIVES 한국생명공학연구원 2022-01-27 WO disclosed
CN-101747254-B Substituent indole compound and application thereof SHENYANG RES INST CHEMICAL IND 2012-07-04 CN disclosed
CN-101747254-A Substituent indole compound and application thereof SHENYANG RES INST CHEMICAL IND 2010-06-23 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230293487-A1 ANTI-INFLAMMATORY COMPOSITION COMPRISING BENZOFURAN-BASED N-ACYLHYDRAZONE DERIVATIVES RELA, NFKBIA, IKBKG KDM4E 2006/4885ALDH1A1 1094/4885GLA 2152/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.